Navigation Links
MedNet Solutions Announces Significant Enhancements to ENLIGHTEN, Its Flagship EDC / eClinical Solution
Date:2/8/2011

MINNETONKA, Minn., Feb. 8, 2011 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce the latest release of ENLIGHTEN®, the company's flagship eClinical solution.  The ENLIGHTEN system, which provides a proven, highly configurable, and easy-to-use electronic data capture (EDC) and clinical trial management system (CTMS), has effectively supported the world-wide clinical research needs of pharmaceutical and medical device companies for over 10 years.

The latest ENLIGHTEN release contains numerous enhancements which fall into three major categories: 1) expanded reporting capabilities that provide users with superior report creation flexibility and increased data visibility, 2) increased configurability to more quickly and easily meet customers' unique, study-specific requirements, and 3) optimized system performance to ensure rapid system response times and a superior user experience.

"For over a decade, ENLIGHTEN has successfully supported clinical studies of all types – from large to small, from early phase trials to post market registries, and across virtually every therapeutic area," remarked Al Sherwood, MedNet's Senior Vice President of Research and Development and co-founder of MedNet Solutions. "Proof of ENLIGHTEN's success is MedNet's exceptionally high level of repeat customer business.  But we're not resting on our laurels…we're committed to continuing to enhance our systems to better meet our customers' evolving needs."

"The last thing a sponsor should have to worry about is their EDC partner," stated John M. (Rob) Robertson, President and CEO of MedNet Solutions.  "And with MedNet, there's no need to worry. From our proven systems to our experienced, hardworking, and responsive staff, MedNet is the eClinical company our customers know they can rely on and trust."

For more information on MedNet Solutions and the ENLIGHTEN EDC / eClinical solution, or to schedule a product demonstration, please call MedNet Solutions at (866) 258-2735, email MedNet at contact@mednetstudy.com, or visit www.mednetstudy.com.

About MedNet SolutionsMedNet Solutions is a leading healthcare technology company specializing in clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based solutions that support our customers' clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, and biotechnology organizations on projects spanning 6 continents and more than 40 countries. MedNet delivers a superior customer experience from beginning to end.  For more information, please visit www.mednetstudy.com. Contact Information:Dirk H. NelsonMarketing Manager110 Cheshire Lane, Suite 300Minnetonka, MN  55305USA(763) 258-2735
'/>"/>

SOURCE MedNet Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse
2. MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse
3. ID Solutions Achieves Full-Production Delivery and Payment for Fingerprint Processing Software for TWIC
4. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
5. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
6. Dont blame cities for climate change, see them as solutions
7. bioMETRX, Inc. Signs Deal To Acquire Controlling Interest in Biometric Solutions, LLC
8. New center will focus environmental debate and produce solutions for action
9. L-1 Identity Solutions Selected by the State of New York as the Winning Bidder to Provide Enrollment Services for a Contract Estimated at Up to $250 Million
10. BIO-key(R) Mobile Data and Messaging Solutions Link Nebraska Law Enforcement Agencies
11. Researchers examine developing hearts in chickens to find solutions for human heart abnormalities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... 27, 2016 , ... Rolf K. Hoffmann, former senior vice ... University of North Carolina Kenan-Flagler Business School effective June 27. , ... with a focus on the school’s international efforts, leading classes and participating in ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology: